A ACELLERA
DEAD

Serial Number

98058423

Owner

ACELLERA THERAPEUTICS, INC.

Attorney

Elizabeth Lee D'Amore

Filing Date

Jun 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

A ACELLERA Trademark

Serial Number: 98058423

A ACELLERA is a trademark filed by ACELLERA THERAPEUTICS, INC. on June 26, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ACELLERA THERAPEUTICS, INC. (6 trademarks)

38350 FREMONT BOULEVARD
FREMONT, CA 94536

Entity Type: 03

Acellera Ltd. (4 trademarks)

Devonshire House, 582 Honeypot Lane
STANMORE HA71JS , GB

Entity Type: 99

Trademark Details

Filing Date

June 26, 2023

Registration Date

Not Registered

Goods & Services

Imaging apparatus and instruments for use in the study of proteins and peptides in drug development; design and development of computer hardware and computer software in the field of drug and chemical development ; computer software for use in molecular research; computer software for use in the research and development of pharmaceutical products; computer software for the analysis of biological or chemical activity; computer software for the design of chemical structures; computer software for cell analysis

Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Drug discovery services; Pharmaceutical drug development services; Drug screening for scientific research purposes; Computer software design; computer consultancy services being computer software consultation in the field of drug and chemical development; software as a service (SAAS) services featuring computer software platforms for use in database management for optimizing drug and chemistry discovery; chemistry services in the nature of drug discovery services; chemical research and chemistry consultation in the field of drug and chemical development; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Consulting services in the field of pharmaceutical research and development; Conducting early evaluations in the field of new pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals; Pharmaceutical research services; Pharmaceutical research and development

Filing History

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Mar 1, 2025 MAB1
ABANDONMENT - EXPRESS MAILED
Mar 1, 2025 ABN1
TEAS EXPRESS ABANDONMENT RECEIVED
Feb 27, 2025 EXAR
ATTORNEY REVIEW COMPLETED
Jan 24, 2025 ATRV
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 9, 2024 CHAN
ASSIGNED TO LIE
Dec 9, 2024 ALIE
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 28, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 28, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 28, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 28, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 28, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 28, 2024 COAR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 13, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 13, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 13, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 18, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 18, 2024 XELR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 1, 2024 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 19, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 19, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 12, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 27, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 26, 2023 NWOS
NEW APPLICATION ENTERED
Jun 29, 2023 NWAP